# Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.

> **NCT06176443** · NA · COMPLETED · sponsor: **The Society of Bariatric and Metabolic Surgeons of Kazakhstan** · enrollment: 300 (actual)

## Conditions studied

- Obesity, Morbid
- Diabetes Mellitus, Type 2

## Interventions

- **PROCEDURE:** One anastomosis gastric bypass with combined fundoplication
- **PROCEDURE:** One anastomosis gastric bypass without combined fundoplication

## Key facts

- **NCT ID:** NCT06176443
- **Lead sponsor:** The Society of Bariatric and Metabolic Surgeons of Kazakhstan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-13
- **Primary completion:** 2024-01-13
- **Final completion:** 2024-05-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06176443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06176443, "Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06176443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*